Dna Group (T.R.) Ltd

Dna Group (T.R.) Ltd's latest marketcap:
As of 07/05/2025, Dna Group (T.R.) Ltd's market capitalization has reached $42.33 M. According to our data, Dna Group (T.R.) Ltd is the 30984th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
Market Cap | 42.33 M |
Revenue (ttm) | 91,604.16 |
Net Income (ttm) | 6.61 M |
Shares Out | 123.16 M |
EPS (ttm) | 0.05 |
Forward PE | 0.00 |
Ex-Dividend Date | n/a |
Earnings Date | 08/24/2025 |
Dna Group (T.R.) Ltd's yearly market capitalization.
Date | Market Cap | Change (%) | Global Rank |
---|---|---|---|
07/05/2025 | ₪42.33 M | 26.43% | 30984 |
12/31/2024 | ₪111.83 M | 43.67% | 31338 |
12/31/2023 | ₪77.84 M | -10.57% | 33318 |
12/29/2022 | ₪87.04 M | -44.63% | 31438 |
12/30/2021 | ₪157.19 M | 586.31% | 27473 |
12/31/2020 | ₪22.9 M | 11.15% | 33121 |
12/31/2019 | ₪20.61 M | -36.54% | 30331 |
12/31/2018 | ₪32.47 M | -52.99% | 28304 |
12/31/2017 | ₪69.08 M | 67.66% | 25546 |
12/29/2016 | ₪41.2 M | 12.82% | 25149 |
Company Profile
About Dna Group (T.R.) Ltd
Dna Group (T.R.) Ltd, along with its subsidiaries, specializes in the development, manufacturing, and marketing of patented ultrasound systems. The company operates globally, with a presence in Israel, North America, East Asia, and other international markets.
Core Offerings
- Ultrasound Systems: Advanced diagnostic tools for assessing bone strength, density, and monitoring calcium leakage (osteoporosis) in both adults and children.
- Target Users: Designed for skilled physicians, nurses, and operators in hospitals, clinics, pharmacies, and other healthcare settings.
- Oral Drug Development: Engages in the research and development of innovative oral medications.
Corporate Background
Formerly known as D.N.A Biomedical Solutions Ltd., the company rebranded to Dna Group (T.R.) Ltd in November 2022. Founded in 2004, it is headquartered in Tel Aviv-Yafo, Israel.
Frequently Asked Questions
-
What is Dna Group (T.R.) Ltd's (TLV-DNA) current market cap?As of 07/05/2025, Dna Group (T.R.) Ltd (including the parent company, if applicable) has an estimated market capitalization of $42.33 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Dna Group (T.R.) Ltd (TLV-DNA) rank globally by market cap?Dna Group (T.R.) Ltd global market capitalization ranking is approximately 30984 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.